First Tracks Biotherapeutics Stock

First Tracks Biotherapeutics P/B

The P/B (Price-to-Book Ratio) of First Tracks Biotherapeutics (TRAX) as of Aug 10, 2026 is 2.11. In the previous year, P/B (Price-to-Book Ratio) was 1.55 — a change of 36.21% (higher).

P/B

2.11

YoY

36.21%

Last updated:

P/B (Price-to-Book Ratio) of First Tracks Biotherapeutics is 2026 2.11 . P/B (Price-to-Book Ratio) of First Tracks Biotherapeutics was 2025 1.55 . It decreases by 36.21% higher compared to the previous year.
Access this data via the Eulerpool API

First Tracks Biotherapeutics Stock analysis

What does First Tracks Biotherapeutics do? First Tracks Biotherapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about First Tracks Biotherapeutics stock

P/B (Price-to-Book Ratio) of First Tracks Biotherapeutics is 2.11 in 2026.

P/B (Price-to-Book Ratio) of First Tracks Biotherapeutics changed from 1.55 to 2.11, representing a 36.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) First Tracks Biotherapeutics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s First Tracks Biotherapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — First Tracks Biotherapeutics

All Key Metrics — First Tracks Biotherapeutics